ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen " Enovis bets big on ortho. CEO Matt Trerotola explains why the company has a winning hand "
Episode Synopsis
In this week’s interview we talk with one of the newer orthopedics players on the block – Enovis, the entity formerly known as Colfax. CEO Matthew L. Trerotola walks us through the decision to move from a diversified industrial player into an orthopedics company and just how the company thinks it can compete against larger, established players in the market. Enovis is weighted heavily in extremities, putting it on a track for fast growth, but sees promising signs it can compete in large joint as well.
You’ll also hear our latest Fastball Patch from Cellular Vehicles. This episode was sponsored by DeviceTalks Boston.
Thank you for listening to the DeviceTalks Weekly podcast.
Subscribe on any major podcast player.
More episodes of the podcast DeviceTalks Podcast Network
May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US
19/12/2025
Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD
12/12/2025
How Enovis is unlocking better bracing with innovative materials, patient comfort & next-gen tech
09/12/2025
How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care
05/12/2025
Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi
26/11/2025
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
In God we trust